Ironwood Pharmaceuticals | IRWD - 资产



金融业
股票价格
USD 4.83
资产
USD 290.59M
现金及等价物
USD 86.38M
销售成本
USD 29.83M
流动资产
USD 225.99M
流动负债
USD 34.73M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD 0.31
股本和储备
USD -97.19M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 759.2M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
204.24
税前利润
USD 68.02M
销售收入
USD 113.04M
销售和管理费用
USD 33.33M
贸易债权人
USD 3.62M
应收帐款人
USD 81.89M


资产 更改 日
Acadia Pharmaceuticals USD 1.79B 51.25M 2026-09
Agios Pharmaceuticals USD 1.06B 44.38M 2026-09
Akebia Therapeutics USD 342.13M 7.53M 2026-09
Almirall EUR 2.37B 29.97M 2026-06
Alnylam Pharmaceuticals USD 7.99B 2.44B 2026-09
Amarin USD 634.08M 9.72M 2026-09
Ardelyx USD 587.52M 11.63M 2026-09
Astellas Pharma JPY 3.53T 164.74B 2026-09
AstraZeneca USD 119.92B 4.09B 2026-09
Charles River Laboratories USD 7.45B 80.64M 2026-09
Coherus Biosciences USD 191.18M 74.84M 2026-06
Emergent BioSolutions USD 1.82B 69.9M 2023-12
Halozyme Therapeutics USD 3.47B 895.94M 2026-09
Incyte USD 7.29B 585.39M 2026-09
Ironwood Pharmaceuticals USD 290.59M 5.46M 2026-09
Karyopharm Therapeutics USD 131.42M 23M 2026-03
Lexicon Pharmaceuticals USD 268.82M 83.83M 2026-03
MacroGenics USD 318.68M 26.72M 2026-09
Moderna USD 13.47B 2.51B 2026-09
Myriad Genetics USD 638.9M 34.8M 2026-06
Pacira USD 34.68B 33.44B 2026-09
PTC Therapeutics USD 3.21B 42.76M 2026-09
Puma Biotechnology USD 202.86M 7.95M 2025-09
Sarepta Therapeutics USD 3.17B 22.45M 2026-09
Takeda JPY 15.27T 391.77B 2026-09
Ultragenyx Pharmaceutical USD 1.19B 77M 2026-09
Vanda Pharmaceuticals USD 488.95M 112.19M 2025-12